Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 19 Jan 2023 for Vyant Bio, Inc.. Read the official filing
Filing timeline
BuySaleGeoffrey E. Harris
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Geoffrey E. Harris: trading record in brief
All filings by Geoffrey E. Harris on record concern Vyant Bio, Inc., in the capacity of board member. The record holds 7 filings, for trades running from 18 January 2022 to 17 January 2023.
On the market, this insider has only sold: 1 sale, €128 in total. Outside the open market, there are 6 share grants.
The latest filing, published on 19 January 2023, reports a share grant in Vyant Bio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Geoffrey E. Harris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,712 sharesCommon Stock, $0.0001 par valueSEC:0001493152-23-001918:0
99 shares@ US$1.34011.4% of flowCommon Stock, $0.0001 par valueSEC:0001493152-22-033340:0
10,841 sharesCommon Stock, $0.0001 par valueSEC:0001493152-22-028717:0
6,141 sharesCommon Stock, $0.0001 par valueSEC:0001493152-22-020760:0
5,157 sharesCommon Stock, $0.0001 par valueSEC:0001493152-22-010475:0
43,478 sharesCommon Stock, $0.0001 par valueSEC:0001493152-22-008829:0
4,055 shares@ US$1.3197.3% of flowCommon Stock, $0.0001 par valueSEC:0001493152-22-001793:0
7 of 7 declarations
